cagon-like peptide-1 and its potent agonist exendin-4 induce several immediate early response genes (IEGs) that code for transcription factors implicated in cell proliferation, differentiation, and apoptosis. We recently observed that early growth response factor-1 (EGR-1), an IEG product, was required for transcriptional activation of Ccnd1 (cyclin D1) gene by exendin-4. Herein, the regulatory mechanism whereby exendin-4 activates the transcription of EGR-1 gene was investigated in the pancreatic ␤-cell line INS-1. Deletion analysis of rat EGR-1 promoter identified a critical region between Ϫ73 and Ϫ46 for the activation of EGR-1 in response to exendin-4. Mutation of the proximal putative cAMP response element (CRE, 5Ј-GTACGTCA-3Ј) located at Ϫ69 resulted in a significant decrease in the EGR-1 transcription, whereas the mutation of the distal putative CRE at Ϫ139 was without such an effect. In immune supershift assays using exendin-4-treated cells, binding of cAMP response element-binding protein (CREB) phosphorylated on Ser 133 to the proximal CRE was increased. Employment of a CREB mutant containing Ala substitution at Ser 133 or a dominant negative CREB mutant that inhibits the binding of endogenous CREB to DNA significantly decreased the exendin-4-induced EGR-1 transcription. In experiments using specific protein kinase inhibitors, the effect of H-89 was more prominent than PD-98059, indicating the predominance of the PKA signaling over the MEK/ERK in induction of EGR-1. Therefore, it appears that the proximal CRE site is critical and the binding with CREB phosphorylated on Ser 133 is necessary for induction of the EGR-1 transcription by exendin-4.
early growth response factor-1; cyclic adenosine monophosphate response element-binding protein; protein kinase A GLUCAGON-LIKE PEPTIDE-1-(7-36) AMIDE (GLP-1), along with its analog exendin-4, is a potent insulinotropic hormone that enhances insulin secretion and whole body insulin sensitivity (8, 25) . They also act as a growth factor that stimulates ␤-cell proliferation and islet neogenesis in diabetic animal models (4, 15, 21) . Activation of the GLP-1 receptor, which is G protein coupled, increases intracellular cAMP level and activates PKA. The cAMP/PKA signaling pathway has been shown to play a pivotal role in maintaining and promoting growth of the ␤-cells (12) . GLP-1 also activates other signaling pathways, such as phosphatidylinositol 3-kinase and mitogen-activated protein kinase, in these cells (15, 21) . In addition, GLP-1 induces immediate early response genes, such as c-FOS, c-JUN, and early growth response factor-1 (EGR-1), that are implicated in ␤-cell growth, differentiation, and apoptosis (21, 22) .
Recently, we (13) reported that exendin-4 induced binding of EGR-1 protein to a cis-regulatory element between Ϫ153 and Ϫ134 on rat Ccnd1 (cyclin D1) promoter leading to activate cyclin D1 transcription. Other studies using small RNA interference demonstrated that reduced EGR-1 gene expression contributed to the decreased ␤-cell proliferation and the consequent ␤-cell failure, supporting the essential role of EGR-1 in normal pancreatic ␤-cell function (7) . EGR-1, also known as Zif268, NHFI-A, Tis8, and Krox24, is a 3-zinc-finger protein of a member of transcription factors, and its expression is rapidly and transiently induced by various extracellular stimuli (1-3, 23, 24) . The induction of EGR-1 has been primarily known to be regulated at the transcriptional level through cis-regulatory elements of the 5Ј-regulatory region of the gene, which contains the binding sites for serum response factor, cAMP response element-binding protein (CREB), activating protein-1 (AP1), E26 (ETS), and EGR-1 itself (2, 3, 18 -20) .
Although the roles of GLP-1 in the proliferation of pancreatic ␤-cells have been widely studied, the molecular mechanisms by which the signaling cascades lead to the regulation of their target gene such as EGR-1 have been less well known. Therefore, we investigated the cis-acting elements and the trans-acting factor involved in regulating EGR-1 gene expression in response to exendin-4 by use of the INS-1 pancreatic ␤-cell line.
MATERIALS AND METHODS
Materials. All culture media, exendin-4, and poly(dI-dC) were purchased from Sigma-Aldrich (St. Louis, MO 32 P]ATP were obtained from PerkinElmer Life Sciences (Boston, MA). LipofectAMINE-PLUS reagent was from Life Technologies (Grand Island, NY). Antibodies to CREB and phosphorylated CREB were from Cell Signaling Technology (Beverly, MA). Anti-EGR-1, -c-JUN, and -Sp1 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA). QuikChange Site-Directed Mutagenesis Kit was from Stratagene (La Jolla, CA). Luciferase assay kit, rabbit anti-(mouse IgG)-peroxidase conjugate, and goat anti-(rabbit IgG)-peroxidase conjugate were from Promega (Madison, WI). PD-98059 and H-89 were from Calbiochem (San Diego, CA).
Cell culture and treatment. INS-1 cells (between passages 15 and 27) were cultured in RPMI 1640 medium (11.5 mM glucose) supplemented with 10% FBS, 2 mM L-glutamine, 50 M 2-mercaptoethanol, 1 mM pyruvate, 100 g/ml streptomycin, and 100 U/ml penicillin at 37°C under an atmosphere of 95% air-5% CO 2. For exendin-4 and inhibitor treatment, cells at an initial density of 1 ϫ 10 5 cells/ml were cultured for 48 h and serum starved with RPMI 1640 (5 mM glucose) for 24 h. After starvation, the cells were treated with exendin-4 or pretreated with inhibitors, as described in the figure legends.
Preparation of nuclear extracts. Cells were washed twice with ice-cold PBS and were pelleted by centrifugation. The pellet was resuspended and incubated for 15 min on ice in a hypotonic solution consisting of 10 mM HEPES, pH 7.9, 1.5 mM MgCl 2, 10 mM KCl, 0.4% Nonidet P-40, 50 mM NaF, 1 mM Na 3VO4, 2.5 mM dithiothreitol, 0.5 mM PMSF, and 1 g/ml leupeptin. Nuclei were collected with centrifugation and incubated for 30 min on ice in a hypertonic buffer consisting of 20 mM HEPES, pH 7.9, 25% glycerol, 0.5 M NaCl, 1.5 mM MgCl 2, 1 mM EDTA, 50 mM NaF, 1 mM Na3VO4, 5 mM dithiothreitol, 0.1 mM PMSF, and 1 g/ml leupeptin. The nuclear extract was prepared by centrifugation and stored at Ϫ80°C prior to use. Protein concentrations were measured with the Bio-Rad Protein Assay (Bio-Rad, Hercules, CA).
Western blotting. Twenty micrograms from each sample were separated on an SDS-polyacrylamide gel. Following electrophoresis, proteins were transferred to PVDF membrane (Amersham Biosciences, Piscataway, NJ). Blocking was performed in 5% nonfat dried milk in PBS containing 0.2% Tween-20. Antibodies used to probe the blots were EGR-1, CREB, phosphorylated CREB, and ␤-tubulin. The detection was performed by chemiluminescence system (Amersham Biosciences).
Northern blotting. Total cellular RNA was extracted using TRIzol reagent (Life Technologies) based on the manufacturer's instructions. Ten micrograms of each sample were fractionated in a 1% formaldehyde agarose gel and transferred onto a Hybond-N nylon membrane (Amersham Biosciences). The membrane was hybridized in a rapid hybridization buffer (Amersham Biosciences) with a 0.7-kilobase rat EGR-1 cDNA labeled with [ 32 P]dCTP (3,000 Ci/mmol) and washed under high-stringency conditions: once with 2ϫ SSC and 0.1% SDS at room temperature for 15 min, once with 2ϫ SSC and 0.1% SDS at 65°C for 15 min, and once with 0.1ϫ SSC and 0.1% SDS at 65°C for 15 min. The membrane was subjected to autoradiography.
Plasmid constructions. The rat EGR-1 promoter fragment spanning from Ϫ462 to ϩ27 was generated by a standard PCR method using genomic DNA from INS-1 cells as a template. The forward primer was 5Ј-TCAGGTACCAGGCTCCGGGTTGGGAAC-3Ј (KpnI site is underlined) and the reverse was 5Ј-TCACTCGAGCCAAGTTCT-GCGCGCTGG-3Ј (XhoI site is underlined). The PCR product digested with KpnI and XhoI was cloned into the promoterless vector pGL3 basic (Promega), designated as p-462. The constructs with serially 5Ј-truncated fragments were synthesized using the p-462 as a template and cloned in the same manner. The forward primers with the KpnI site at the 5Ј end (underlined) were as follows: for p-324, 5Ј-TCAGGTACCTGCGCTTCCGGCTCTG-3Ј; for p-243, 5Ј-TCAGGTACCGCCACTGCCGCTGTTCC-3Ј; for p-159, 5Ј-TCAGGTACCCCGCTCTTGGATGGGAGGTC-3Ј; for p-124, 5Ј-TCAGGTACCGTCCTCCCGGTCGGTCC-3Ј; for p-73, 5Ј-TCAGGTACCCCATGTACGTCACGGCGGAG-3Ј; for p-46, 5Ј-TCAGGTACCCGTGCTGTTTCAGACCCTTG-3Ј. The reverse primer was the same as that used in p-462.
Site-directed mutagenesis. The mutant CRE constructs were prepared with a QuikChange Site-Directed Mutagenesis Kit according to the manufacturer's protocol. The top strand of the primer set was as follows: for mpCRE-462 and mpCRE-73, 5Ј-ATATATGGCCATGT-TGGTCACGGCGGAGGC-3Ј, and for mdCRE-462, 5Ј-GATGG-GAGGTCTTCTGGTCACTCCGGGTCC-3Ј. The two underlined nucleotides in the putative CRE sites were changed from AG (wild type) to TG. The mutation was verified by DNA sequence analysis.
Transient transfection and luciferase activity assay. Constructs of EGR-1 promoter-luciferase reporter gene were transiently transfected into INS-1 cells (0.5 g/2 ϫ 10 5 cells) without or with wild-or mutant-type CREB vector (1 g) using LipofectAMINE-PLUS reagent. To control transfection efficiency and to normalize luciferase values in all experiments, pSV-␤-galactosidase (Promega) was used as an internal control. The fold induction was determined by dividing the luciferase activity of the exendin-4-treated cells by that of the untreated cells.
Electrophoretic mobility shift assay. Binding reaction to allow to form DNA/protein complexes was performed in 20 l of 10 mM HEPES, pH 8, 0.1 mM EDTA, 50 mM NaCl, 50 mM KCl, 5 mM MgCl 2, 2 mM dithiothreitol, 10% glycerol, 1 g of poly(dI-dC), 32 P-labeled oligonucleotide probe (30,000 cpm), and 5 g of nuclear extract. The reaction was allowed to continue for 15 min at 4°C. In supershift studies, 2 g of the appropriate antibody were preincubated with the nuclear extract for 15 min at 4°C before addition of the labeled probe. In competition experiments, the nuclear extract was incubated with a 100-fold molar excess of the appropriate unlabeled competitor oligonucleotides. Electrophoresis was carried out on 6% nondenatured polyacrylamide gels with 0.5ϫ TBE (15 V/cm for ϳ2 h). The gel was dried under vacuum and subjected to autoradiography. Oligonucleotides used were as follows: CRE, 5Ј-CCATGTACGTCACGGCGGAG-3Ј; CRE mutant, 5Ј-CCATGTtgGTCACGGCGGAG-3Ј; CRE consensus, 5Ј-AGAGATTGC-CTGACGTCAGAGAGCTAG-3Ј; AP1 consensus, 5Ј-CGCTT-GATGACTCAGCCGGAA-3Ј; and Sp1 consensus, 5Ј-ATTC-GATCGGGGCGGGGCGAGC-3Ј.
Chromatin immunoprecipitation assays. Chromatin immunoprecipitation (ChIP) assays were performed with a ChIP assay kit (Upstate Biotechnology, Grand Island, NY) according to the manufacturer's instructions. The conditions for PCR were as follows: 30 s at 95°C, 30 s at 62°C, and 30 s at 72°C for 25 cycles, with a final extension for 10 min at 72°C. Primers for ChIP were forward 5Ј-GTCCTCCCGGTCGGTCCTTC-3Ј and reverse 5Ј-GATCCCAG-CGCGCAGAACTTGG-3Ј.
Statistical analysis. Data are expressed as means Ϯ SD. Statistical analysis was performed using one-way ANOVA and Student's t-test. P Ͻ 0.05 was accepted as statistically significant.
RESULTS

Activation of rat EGR-1 gene in response to exendin-4 in INS-1 cells. INS-1 cells transiently transfected with p-462
construct containing full-length EGR-1 promoter (from Ϫ462 to ϩ27) were serum-starved and treated with varying concentrations of exendin-4 (10 Ϫ10 , 10 Ϫ9 , 10 Ϫ8 , and 10 Ϫ7 M). As shown in Fig. 1A , exendin-4 induced the activity of the reporter gene in a dose-dependent manner, starting to induce at 10 Ϫ9 M and peaking at 10 Ϫ8 M without a further increase at 10 Ϫ7 M. In examination of the kinetics of EGR-1 expression, exendin-4 (10 Ϫ8 M) rapidly and transiently induced the expression of EGR-1 mRNA. The mRNA was detectable within 15 min after exendin-4 treatment, reaching maximum level at 30 min and sharply declining thereafter (Fig. 1B) . The time course of the mRNA expression was well correlated with the kinetics of EGR-1 protein induction. The protein level started to increase within 30 min, peaked at 1 h, and returned to basal level by 2 h of exendin-4 treatment (Fig. 1C) . In another pancreatic ␤-cell line, RINm5F, exendin-4 treatment showed a similar response pattern of EGR-1 induction observed in INS-1 cells (data not shown).
Determination of exendin-4 response elements of the rat EGR-1 promoter.
The 5Ј-regulatory region of rat EGR-1 promoter contains several putative binding sites for transcription factors, which are known to mediate transcriptional activation of human EGR-1 gene (18 -20) . These regulatory sites include five sterol response elements (SREs), two ETSs, and two CREs. To determine the regulatory elements involved in inducing the rat EGR-1 gene in response to exendin-4, a series of 5Ј deletion constructs of the rat EGR-1 promoter were transiently transfected, and then the activities of the reporter gene were analyzed. As shown in Fig. 2 , two regions were responsive to exendin-4, i.e., between Ϫ462 and Ϫ324 (designated as 5Ј-responsive region) and between Ϫ73 and Ϫ46 (designated as 3Ј-responsive region). The p-462, a full-length construct, showed an ϳ2.1-fold increase in promoter activity by exendin-4. Further serial deletion to Ϫ73, which eliminated five SREs and a distal CRE, maintained relatively constant responses of 1.6-to 1.7-fold induction. However, the deletion to Ϫ46, which eliminated the remaining proximal CRE site, resulted in a complete loss of the exendin-4 response. Thus, the 3Ј responsive region between Ϫ73 and Ϫ46 proved to be a principal site for induction of the EGR-1 gene activity in response to exendin-4. On the other hand, the 5Ј-responsive region between Ϫ462 and Ϫ324 may be required for the full activation of the EGR-1 promoter.
Significant inhibition of exendin-4-induced EGR-1 transcription by mutation of the proximal CRE.
To evaluate the functional significance of the proximal CRE site for the activation of the EGR-1 promoter by exendin-4, the proximal CRE sequences (5Ј-GTACGTCA-3Ј) of the p-462 or p-73 construct were mutated to 5Ј-GTtgGTCA-3Ј. The distal CRE site located at Ϫ139 (5Ј-TCACGTCA-3Ј) was also mutated to 5Ј-TCtcGTCA-3Ј, as this distal CRE site was also shown to be involved in the regulation of the human EGR-1 gene by growth factors (5, 6, 18) . As shown in Fig. 3 , the introduction of the mutated proximal CRE into the p-462 construct (mpCRE-462) reduced the fold induction by ϳ28% compared with wild p-462 construct (1.5 Ϯ 0.1 vs. 2.1 Ϯ 0.2, P Ͻ 0.05), whereas the introduction of the same mutant CRE into the p-73 construct (mpCRE1-73) abolished the exendin-4 response compared with wild p-73 construct (1.0 Ϯ 0.1 vs. 1.7 Ϯ 0.1, P Ͻ 0.05). On the other hand, mutation of the distal CRE (mdCRE-462) decreased the fold induction by only 12% compared with the wild p-462 construct (1.8 Ϯ 0.1 vs. 2.1 Ϯ 0.2, P Ͻ 0.05). These results confirmed the critical role of the 3Ј-responsive region and the importance of the proximal CRE in activating the EGR-1 gene in response to exendin-4.
Induction of CREB phosphorylated on Ser 133 associated with the proximal CRE site by exendin-4. To determine the nuclear factors bound to the proximal CRE site, electrophoretic mobility shift assays (EMSAs) were performed using nuclear extracts from exendin-4-treated INS-1 cells and a radiolabeled probe containing the proximal CRE sequence. As shown in Fig. 4A , the relative intensity of each band was irrelevant to the duration of exendin-4 treatment. The binding specificities of these complexes were determined using unlabeled oligonucleotides. The complexes were completely eliminated by 100-fold excess of unlabeled consensus or wild CRE oligonucleotides but not affected by mutant CRE oligonucleotide (Fig. 4B) . Because the proximal CRE sequence of the radiolabeled probe used in this experiment also holds potential binding sites for c-JUN, one of the AP1 subunits, and Sp1 as shown in Fig. 4B , bottom, consensus AP1 and Sp1 oligonucleotides were also tested and proved to be without effect. Next, nuclear factors binding to the proximal CRE site were identified using relevant antibodies. As shown in Fig. 4C , incubation with an antibody against CREB resulted in a supershifted complex formation with similar intensity regardless of exendin-4 treatment. However, from the exendin-4-treated nuclear extract, an antibody (anti-pCREB) that specifically recognizes the CREB phosphorylated on Ser 133 , picked up a clear, supershifted band that was not detectable from the untreated nuclear extracts. The presence of phosphorylated CREB observed in the supershift assays was confirmed by Western blot analysis using the same nuclear extracts and the anti-phospho-CREB antibody. Exendin-4 treatment substantially induced the phosphorylation of CREB without affecting the levels of CREB proteins (Fig. 4D) . Next, the in vivo effect of exendin-4 on the induction of the phosphorylation at Ser 133 of CREB bound to rat EGR-1 promoter was examined by ChIP assay. The immunoprecipitated DNAs were amplified by standard PCR using a pair of primers flanking the proximal CREB-binding region (Ϫ124 to ϩ27) of the EGR-1 promoter. As shown in Fig. 4E, in Exendin-4 induction of EGR-1 expression via PKA and ERK signaling pathways. To investigate the signaling pathway for the exendin-4 induction of EGR-1 expression, specific kinase inhibitors (H-89 for PKA and PD-90059 for MEK) were used. As shown in Fig. 5A , at concentrations commonly used for the inhibition of PKA and MEK activities, pretreatment with H-89 (10 M) completely inhibited the exendin-4 response, whereas PD-98059 (50 M) decreased the response by 36%. In parallel with the transfection results, Western blot analysis showed that the exendin-4 induction of phosphorylation of CREB on Ser 133 and of EGR-1 protein were completely blocked by H-89 but partly by PD-98059 (Fig. 5B) . These results indicate that the PKA signaling pathway is more important for the exendin-4 activation of EGR-1 gene and for the phosphorylation of CREB than the MEK/ERK pathway. -JUN) , or Sp1 (anti-Sp1). Nuclear extracts with exendin-4 treatment for 15 min were preincubated with antibodies for 15 min before addition of radiolabeled probe. D: Western blot analysis of phospho-CREB (p-CREB) and CREB using the same nuclear extracts used for supershift assays. E: ChIP assay was performed to amplify the region from Ϫ124 to ϩ27. Input samples represent 0.001, 0.005, and 0.01% of total DNA, whereas PCRs of the immunoprecipitations include 5% of the resuspended DNA. IgG antibody was used as a negative control. Similar results were obtained from 3 independent experiments. 
DISCUSSION
Accumulating evidence strongly indicates that GLP-1 and its potent analog exendin-4 possess properties of enhancing pancreatic ␤-cell growth and differentiation and of suppressing ␤-cell apoptosis in both in vivo and in vitro models (4, 15, 21) . In an effort to clarify the molecular mechanism of GLP-1 in regulating ␤-cell proliferation, we (13) recently found that exendin-4 induced EGR-1 to bind the putative EGR-1 binding site of rat cyclin D1 promoter, leading to the transactivation of cyclin D1 gene. In this study, we further showed that the proximal CRE site of rat EGR-1 promoter in association with CREB phosphorylated on Ser 133 contributed substantially to the transcriptional activation of EGR-1 gene in response to exendin-4 in INS-1 cells.
In humans, the rapid and transient activation of EGR-1 gene expression by many extracellular stimuli is mediated exclusively through the cis-regulatory elements within the 5Ј-regulatory region of the gene without involving posttranscriptional regulation such as mRNA stability. The rapid induction of EGR-1 gene is highly dependent on the binding sites for serum response factor, ternary complex factors, and CREB on the EGR-1 promoter. However, the molecular mechanism for the transient induction of EGR-1 gene is not well known. A negative feedback loop is suggested to downregulate the transcription, in which the EGR-1 protein can bind to the EGR-1 binding site of its own gene and allows only a transient activation of EGR-1 gene. In this study, our determination of the kinetics for induction of EGR-1 mRNA following exendin-4 treatment was well consistent with most other studies in that EGR-1 mRNA was induced within 15 min and significantly reduced after 30 min (2, 5, 22) . The rapid and transient induction of EGR-1 mRNA, together with the activation of EGR-1 promoter, indicates the transcriptional regulation as a fundamental mechanism for the exendin-4 induction of EGR-1 gene.
Through serial-deletion analysis of rat EGR-1 promoter, we mapped the 5Ј-and 3Ј-responsive regions, which were located between Ϫ462 and Ϫ324 and between Ϫ73 and Ϫ46, respectively. Although the 5Ј-responsive region contains the SRE cluster and ETS sites important for EGR-1 transcription in human and mouse (3, 5, 18) , and the region hence appears to be required for the full activation of the EGR-1 promoter in response to exendin-4, we focused our interest on the 3Ј-responsive region between Ϫ73 and Ϫ46. The reasons are as follows. First, deletion of this particular region eliminated almost completely the exendin-4 response, providing this region as a minimally essential promoter. Second, this region contains a proximal putative CRE site that could be the final target of the classic cAMP/PKA signaling pathway for GLP or exendin-4 (15).
Our site-directed mutation of the proximal CRE within the 3Ј-responsive region resulted in a complete loss of the responsiveness to exendin-4, confirming that the CRE is crucial in inducing the activation of the 3Ј-responsive region. The importance of the equivalent CRE in activating the gene was also reported with the human EGR-1 promoter (14, 19) . The 3Ј-responsive regions of rat and human hold 100% identically conserved proximal CRE site (5Ј-GTACGTCA-3Ј) extended from Ϫ69 to Ϫ62. However, the introduction of the mutated proximal CRE into p-462 construct resulted in only a one-third loss of the exendin-4 response instead of abolition of the response. This result might be attributed to the action of intact SRE cluster and ETS sites located within the 5Ј-responsive region between Ϫ462 and Ϫ324.
On the other hand, the distal CRE of human EGR-1 promoter has been shown to be involved in inducing EGR-1 genes (2, 5, 6, 18). In support of these studies, we also observed that mutation of the distal CRE of rat EGR-1 promoter resulted in a significant decrease in the exendin-4 induction of EGR-1 gene, although less than that of the proximal CRE (mdCRE-462 vs. mpCRE-462, Fig. 3) . Interestingly, the deletion effect of the distal CRE at Ϫ139 on induction of EGR-1 promoter activation was negligible in our deletion analysis study (p-159 vs. p-124, Fig. 2) . The discrepancy between the two studies is not clear; however, the strong stimulatory effect of the proximal CRE might have masked the effect of the distal CRE. Likewise, in human EGR-1 promoter, the importance of distal CRE was revealed only by mutation assay but not by deletion analysis (6) .
CREB, a ubiquitously expressed transcription factor, plays a critical role in mediating many cellular responses to various physiological stimuli (16, 17) . CREB activation is generally mediated through phosphorylation on the critical residue Ser 133 within its kinase-inducible domain (16) . The phosphorylation of CREB facilitates its association with the transcriptional coactivators such as CREB-binding protein, leading to promote the expression of CREB target genes. In our supershift and ChIP assays using an antibody against a phosphorylated CREB on Ser
133
, the binding activity of phospho-CREB was remarkably increased following treatment with exendin-4 in vitro and in vivo. In addition, cotransfection data also showed that overexpression of mutant CREB vectors resulted in a significant reduction of the activity of EGR-1 promoter. The involvement of CREB phosphorylation in our study is very well consistent with human EGR-1 studies showing that rapid phosphorylation of CREB mediated the activation of the promoter via binding to the proximal CRE site (14) . These and our findings strongly indicate that exendin-4-induced phosphorylation of CREB is an important step in the transcriptional activation of EGR-1 gene.
Among multiple signaling pathways, PKA and ERK pathways have been well known to mediate EGR-1 expression in response to extracellular mitogens (1-3, 10, 24) . In pancreatic ␤-cells, cAMP/PKA/CREB pathway induced by GLP-1 or exendin-4 is believed to be a critical signaling pathway for cell survival and growth (12) . In addition, the PKA signaling pathway was shown to mediate the induction of EGR-1 in insulinoma cell line MIN6 under high glucose concentration (2) . In other cell types, the cAMP/PKA pathway has been suggested to cross-talk with Rap1/ Raf/MEK to activate ERK (9) . According to our observation employing pharmacological inhibitors, H-89 was more potent in suppressing the exendin-4-activated EGR-1 gene expression as well as pCREB induction than PD-98059, suggesting that the PKA pathway is mainly involved in exendin-4-induced EGR-1 expression. However, further experiments are required to clarify the exact signaling pathway for EGR-1 transcriptional activation by exendin-4 in ␤-cells.
In conclusion, this study represents an important mechanism by which exendin-4 modulates the transcription of EGR-1 gene, the regulation of which is necessary for pancreatic ␤-cell growth.
